ReviewCurrent rheumatology reports2019
An Update on Diagnosis and Classification of Axial Spondyloarthritis.
Review in Current rheumatology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Associations of blood cell indices with the risk of ankylosing spondylitis: A retrospective case-control and machine learning modeling study.SAGE open medicine · 2026Article
- Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study.Scientific reports · 2024Article
- A glance into the future of diagnosis and treatment of spondyloarthritis.Therapeutic advances in musculoskeletal disease · 2022Review
- Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation.Frontiers in immunology · 2022Article
- Paravertebral Muscle Mechanical Properties in Patients with Axial Spondyloarthritis or Low Back Pain: A Case-Control Study.Diagnostics (Basel, Switzerland) · 2021Article
- Understanding the paradigm of non-radiographic axial spondyloarthritis.Clinical rheumatology · 2021Review
- Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative study.PloS one · 2021Article
- Axial spondyloarthritis 10 years on: still looking for the lost tribe.Rheumatology (Oxford, England) · 2020Review
- Secukinumab-induced Raynaud's phenomenon: first report in the literature.Therapeutic advances in drug safety · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTo summarize the most relevant recent progress to diagnose and classify patients with axial spondyloarthritis (axSpA). RECENT
findingsA substantial proportion of new studies focused on the diagnosis and classification of patients with axSpA. Efforts have been concentrated on setting the best strategy to refer patients with suspected axSpA and evaluating the utility of different tools during the diagnostic work-up, especially of imaging techniques. On top of this, researchers have worked on addressing some concerns raised about the employment of the Assessment of SpondyloArthritis international Society classification criteria, especially those related to the validity and misuse of the criteria, providing valuable data on this regard. Recent findings emphasize that classification should serve a completely different purpose than diagnosis. In addition, they highlight the importance to consider the limitations for imaging acquisition, the appropriate context, and differential diagnosis when interpreting imaging findings during the diagnostic work-up of patients with suspected axSpA.
Indexed as
Identifiers
31203462What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.